TL;DR: Gamgee is a Y Combinator Summer 2026 startup Scalable Personalised Cancer Treatment, currently active with a team of 2.
Scalable Personalised Cancer Treatment
Last verified:
Gamgee is building an end to end platform for personalised mRNA cancer vaccines for dogs. We sequence a dog’s tumour and healthy DNA, identify mutations unique to its cancer, and design a vaccine that teaches the immune system what to attack. We manage the entire process- from vet intake and tissue collection through genomic analysis, vaccine production, treatment and response monitoring Gamgee began with Rosie, founder Paul Conyngham’s dog. After surgery, chemotherapy and immunotherapy failed, Rosie was given months to live. Paul used AI and genomic analysis to identify targets in her tumour, then worked with scientists at UNSW to produce what is believed to be the first fully computationally designed mRNA cancer vaccine delivered to a dog. Following treatment, several tumours shrank si…
Built by LemStudio
Yes. Gamgee was funded by Y Combinator in the Summer 2026 batch. Scalable Personalised Cancer Treatment
Gamgee is building an end to end platform for personalised mRNA cancer vaccines for dogs. We sequence a dog’s tumour and healthy DNA, identify mutations unique to its cancer, and design a vaccine that teaches the immune system what to attack. We manage the entire process- from vet intake and tissue collection through…
Gamgee was part of Y Combinator's Summer 2026 batch.
Gamgee has a team of 2 people according to Y Combinator's directory.
Gamgee is currently listed as Active with a team of 2 in Y Combinator's directory.
Loading interactive view…